Alexza Pharmaceuticals

Alexza Pharmaceuticals is owned by Grupo Ferrer. Grupo Ferrer has a direct presence in 2 countries.

View the org chart displaying its 5 main executives

Most searched biographies at Alexza Pharmaceuticals

• Tatjana Naranda, President and Chief Operating Officer
• Stacy Palermini, Senior Vice President, Finance
• Wolfgang Schmid, Vice President, Manufacturing and Operations

Create your alert
to follow the executive moves at Alexza Pharmaceuticals.

Grupo Ferrer has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Alexza Pharmaceuticals

Social media about Alexza Pharmaceuticals

• Alexza Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Alexza Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Tatjana Naranda

Call Alexza Pharmaceuticals at +1 650...

View the org chart

Register to receive your alert

Report an error